Skip to main content
SpringerLink
Log in

Im Vorfeld intensiv beraten!

Senioren auf Reisen

Travel medicine — characteristics in the elderly

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hill DR: Health problems in a large cohort of Americans traveling to developing countries J Travel Med 2000; 7:259–266

    Article  CAS  PubMed  Google Scholar 

  2. Scoville SL, Bryan JP, Tribble D: Epidemiology,preventive services and illnesses of international travellers. Mil Med 1997; 162:172–178

    CAS  PubMed  Google Scholar 

  3. Gautret P, Gaudart J, Leder K, Schwartz E, Castelli F, Lim PM, Murphy H, Keystone J, Cramer J, Shaw M, Boddaert J, von Sonnenburg F, Parola P; GeoSentinelSurveillance Network: Travel associated illnesses in older adults (>60y). J Travel Med 201219(3):169–177

    Article  PubMed  Google Scholar 

  4. Suzuki M, Dhoubhadel BG, Ishifuji et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharid vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis 2017, published online January 23, 2017

  5. Mutsch M, Tavernini M, Marx A, Gregory V, Lin YP, Hay AJ, Tschopp A, Steffen R. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis. 2005 May 1;40(9):1282–7

    Article  PubMed  Google Scholar 

  6. Committee to Advise on Tropical Medicine and Travel (CATMAT); National Advisory Committee on Immunization (NACI): Statement on travel, influenza, and prevention. Can Commun Dis Rep. 2005 Mar 15;31 (ACS-2):1–8)

    Google Scholar 

  7. Gasparini R, Amicizia D, Lai PL, Rossi S, Panatto D. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study. Hum Vaccin Immunother. 2013; 9(1): 144–52.)

    Article  CAS  PubMed  Google Scholar 

  8. Spadea A, Unim B, Colamesta V, Meneghini A, D’Amici AM, Giudiceandrea B, La Torre G. Is the adjuvanted influenza vaccine more effective than the trivalentinactivated vaccine in the elderly population? Results of a case-control study. Vaccine 2014 Sep 15;32(41):5290–4.)

    Article  CAS  PubMed  Google Scholar 

  9. Sullivan SJ, Jacobson R, Poland GA Review Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev Vaccines. 2010 Oct; 9(10):1127–33, Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP.Fluzone® High-Dose Influenza Vaccine. Expert Rev Vaccines. 20169

    Article  CAS  PubMed  Google Scholar 

  10. Richardson DM, Medvedeva EL, Roberts CB, Linkin DR; Centers for Disease Control and Prevention Epicenter Program. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans. Clin Infect Dis. 2015 Jul 15;61(2):171–6

    Article  PubMed  Google Scholar 

  11. van der Linden M, Falkenhorst G, Perniciaro S, Imöhl M. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. PLoS One. 2015 Jul 1;10(7):e0131494

    Article  PubMed  PubMed Central  Google Scholar 

  12. Falkenhorst G, Leidel J, Bogdan C. Pneumokokken-Impfung (2): Plädoyer für STIKO-Empfehlungen. Dtsch Arztebl 2017; 114(1-2): A–28 / B-25 / C-25

    Google Scholar 

  13. Sitarska-Gołebiowska J, Zieliñski A. [Tetanus in 2001]. Przegl Epidemiol. 2003;57(1):135–7

    PubMed  Google Scholar 

  14. Jelenik Z, Keller M, Briggs B, Günther G, Haglund M, Hudeckova H, Jilkova E, Mickiene A, Sandell B, Steffen R, Strle F. Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE). Wien Med Wochenschr. 2010 May;160(9-10):247–51

    Article  PubMed  Google Scholar 

  15. Wissenschaftliche Begründung zur Änderung der Gelbfieber-Impfempfehlung aufgrund der Änderungen in den Regelungen der Internationalen Gesundheitsvorschriften zu Gelbfieber Epid. Bull. 35/2015

  16. Hayes EB. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg. 2007 Oct;101(10):967–71

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Geriatrie und Gelbfieberimpfstation, Alexianer Krefeld GmbH, Dießemer Bruch 81, D-47805, Krefeld, Deutschland

    Andreas H. Leischker M.A.

  2. Geriatrische Klinik und Tagesklinik, Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Schwelm, Deutschland

    Hans Jürgen Heppner (Chefarzt)

Authors
  1. Andreas H. Leischker M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Jürgen Heppner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas H. Leischker M.A..

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leischker, A.H., Heppner, H.J. Senioren auf Reisen. MMW - Fortschritte der Medizin 159, 50–54 (2017). https://doi.org/10.1007/s15006-017-9792-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-017-9792-1

Keywords

Search

Navigation